Back

Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody

1 September 2024 (11:12 - 11:24)
Organised by: Logo
Congress Presentation Part of: Smaller trials and other studies on atherosclerosis Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Frans Berend Mensink

Radboud University Medical Centre, Nijmegen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease
Doctor N. Nerlekar (Clayton, AU)
Slides Video
Presentation thumbnail
Treatment of periodontitis and progression of subclinical atherosclerosis: a randomized controlled clinical trial
Doctor F. D'Aiuto (London, GB)
Slides Video
Presentation thumbnail
Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis
Professor C. Mazer (Toronto, CA)
Slides Video
Presentation thumbnail
Quantified characterization of atherosclerotic plaques by optical coherence tomography attenuation imaging
Doctor S. Zhou (Beijing, CN)
Slides Video

Access the full session

Session thumbnail
Smaller trials and other studies on atherosclerosis
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:12 CET
You may be interested in
thumbnail
Congress Session
Smaller trials and other studies on atherosclerosis
thumbnail
Congress Session
Late-breaking science on acute coronary syndromes
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources